Literature DB >> 7679660

B-cell activation following murine cytomegalovirus infection: implications for autoimmunity.

P Price1, S D Olver, A E Gibbons, G R Shellam.   

Abstract

Infection of susceptible mice with murine cytomegalovirus (MCMV) induces persistent inflammation, and the production of autoantibodies reactive with large numbers of proteins from all major organs. However the roles of polyclonal B-cell activation, autoreactive T-helper cells and host-virus cross-reactions in these phenomena have not been evaluated. The present study reveals six- to 20-fold increases in serum immunoglobulin levels in MCMV-infected BALB/c and CBA mice, with IgG3 and IgG2b most affected. Titres of antibodies reactive with autologous tissues and ovalbumin (OVA) also increased following MCMV infection, whilst responses to a synthetic antigen [polyvinyl pyrrolidone (PVP)] were unaffected or depressed. IgG2a was the isotype most affected in responses to OVA, MCMV antigens and autologous tissues, suggesting interferon-gamma (IFN-gamma) may contribute to responses induced in the presence of the relevant antigen. Increases in total and antigen-specific immunoglobulin levels were CD4 dependent, as they were reduced in infected mice depleted of these cells with anti-CD4 antibodies. Serological changes were preceded by B-cell expansion and activation evident from increased cell yields, frequencies of cells releasing immunoglobulin and proliferation of T-depleted spleen and lymph node preparations. Numbers of mature B cells and macrophages increased in the lymph nodes, but B-1a (CD5+ Ig+) cell counts remained low. Alterations in the B-cell phenotypic profiles were more complex in the spleen, but correction for increased cell yields revealed increases in some subpopulations.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7679660      PMCID: PMC1421784     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  29 in total

1.  Smooth-muscle antibodies and other tissue antibodies in cytomegalovirus infection.

Authors:  P Andersen; H K Andersen
Journal:  Clin Exp Immunol       Date:  1975-10       Impact factor: 4.330

Review 2.  The status of CMV as a human pathogen.

Authors:  P D Griffiths; J E Grundy
Journal:  Epidemiol Infect       Date:  1988-02       Impact factor: 2.451

3.  A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells.

Authors:  J D Sedgwick; P G Holt
Journal:  J Immunol Methods       Date:  1983-02-25       Impact factor: 2.303

4.  Multiple autoantibodies following cytomegalovirus infection: virus distribution and specificity of autoantibodies.

Authors:  W N Bartholomaeus; H O'Donoghue; D Foti; C M Lawson; G R Shellam; W D Reed
Journal:  Immunology       Date:  1988-07       Impact factor: 7.397

5.  Antibody responses to murine cytomegalovirus in genetically resistant and susceptible strains of mice.

Authors:  C M Lawson; J E Grundy; G R Shellam
Journal:  J Gen Virol       Date:  1988-08       Impact factor: 3.891

6.  Host genetic factors influence murine cytomegalovirus lung infection and interstitial pneumonitis.

Authors:  J D Shanley
Journal:  J Gen Virol       Date:  1984-12       Impact factor: 3.891

7.  The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells.

Authors:  A A Scalzo; N A Fitzgerald; C R Wallace; A E Gibbons; Y C Smart; R C Burton; G R Shellam
Journal:  J Immunol       Date:  1992-07-15       Impact factor: 5.422

8.  Isotypically restricted activation of B lymphocytes by lactic dehydrogenase virus.

Authors:  J P Coutelier; J Van Snick
Journal:  Eur J Immunol       Date:  1985-03       Impact factor: 5.532

9.  Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells.

Authors:  T L Stevens; A Bossie; V M Sanders; R Fernandez-Botran; R L Coffman; T R Mosmann; E S Vitetta
Journal:  Nature       Date:  1988-07-21       Impact factor: 49.962

10.  B cell activation by cytomegalovirus.

Authors:  L M Hutt-Fletcher; N Balachandran; M H Elkins
Journal:  J Exp Med       Date:  1983-12-01       Impact factor: 14.307

View more
  12 in total

1.  Use of transgenic HLA A*0201/Kb and HHD II mice to evaluate frequency of cytomegalovirus IE1-derived peptide usage in eliciting human CD8 cytokine response.

Authors:  Ghislaine Gallez-Hawkins; Maria C Villacres; Xiuli Li; Margaret C Sanborn; Norma A Lomeli; John A Zaia
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

2.  Retrovirus-induced target cell activation in the early phases of infection: the mouse mammary tumor virus model.

Authors:  C Ardavin; F Luthi; M Andersson; L Scarpellino; P Martin; H Diggelmann; H Acha-Orbea
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  The roles of tumour necrosis factor-alpha, interleukin-1 and interleukin-12 in murine cytomegalovirus infection.

Authors:  S T Yerkovich; S D Olver; J C Lenzo; C D Peacock; P Price
Journal:  Immunology       Date:  1997-05       Impact factor: 7.397

4.  Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays.

Authors:  H Zhu; J P Cong; G Mamtora; T Gingeras; T Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

5.  Use of a murine cytomegalovirus K181-derived bacterial artificial chromosome as a vaccine vector for immunocontraception.

Authors:  Alec J Redwood; Martin Messerle; Nicole L Harvey; Christopher M Hardy; Ulrich H Koszinowski; Malcolm A Lawson; Geoffrey R Shellam
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

6.  Non-antigen-specific B-cell activation following murine gammaherpesvirus infection is CD4 independent in vitro but CD4 dependent in vivo.

Authors:  P G Stevenson; P C Doherty
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

7.  Cytomegalovirus hepatitis: characterization of the inflammatory infiltrate in resistant and susceptible mice.

Authors:  S D Olver; P Price; G R Shellam
Journal:  Clin Exp Immunol       Date:  1994-12       Impact factor: 4.330

8.  Apoptosis mediated by Fas but not tumor necrosis factor receptor 1 prevents chronic disease in mice infected with murine cytomegalovirus.

Authors:  M Fleck; E R Kern; T Zhou; J Podlech; W Wintersberger; C K Edwards; J D Mountz
Journal:  J Clin Invest       Date:  1998-10-01       Impact factor: 14.808

9.  Bone marrow atrophy induced by murine cytomegalovirus infection.

Authors:  A E Gibbons; P Price; G R Shellam
Journal:  Immunology       Date:  1994-07       Impact factor: 7.397

10.  Autoimmune response to U1 small nuclear ribonucleoprotein (U1 snRNP) associated with cytomegalovirus infection.

Authors:  M M Newkirk; W J van Venrooij; G S Marshall
Journal:  Arthritis Res       Date:  2001-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.